Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on: December 22,2023

Lung cancer screening increases percentage of Stage I cases detected, while reducing percentage of Stage IV cases

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainImplementing lung cancer screening at four diverse healthcare systems resulted in an 8.4 percent increase in t

Updated on:December 22,2023

Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology

Updated on: December 02,2024

Scientists create an scRNA-seq atlas of the multiple myeloma immune microenvironment across disease stages

byVIB (the Flanders Institute for Biotechnology)The MM microenvironment is characterized by the presence of T cells with an exhausted phenotype. Credit:Journal of Hematology & Oncology

Updated on:December 02,2024

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial

Updated on: December 18,2023

Radiation/cisplatin combination established as standard of care for HPV+ oral cancer

byAmerican Society for Radiation OncologyCombinations of radiation and chemotherapy drugs have been shown to cure HPV-related head and neck cancer with a high success rate. A new phase III trial

Updated on:December 18,2023

How cellular plasticity drives cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainAbout 90% of deaths from cancer are a result of metastasis—that is, from cancer's ability to spread from

Updated on: April 28,2024

How cellular plasticity drives cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainAbout 90% of deaths from cancer are a result of metastasis—that is, from cancer's ability to spread from

Updated on:April 28,2024

Molecular jackhammers drill pathway to killing cancer cells  

JANUARY 19, 2024by Michelle Revels,Texas A&M University College of EngineeringResearchers have developed a technique that employs nanoscopic molecular jackhammers capable of cracking a cell&

Updated on: March 15,2024

Molecular jackhammers drill pathway to killing cancer cells  

JANUARY 19, 2024by Michelle Revels,Texas A&M University College of EngineeringResearchers have developed a technique that employs nanoscopic molecular jackhammers capable of cracking a cell&

Updated on:March 15,2024

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on: August 26,2024

Study explores how antifragility in complex dynamical systems could revolutionize cancer treatment

byH. Lee Moffitt Cancer Center & Research InstituteAntifragility-associated terms, defined for technical and natural (biological) systems. Credit:npj Complexity(2024). DOI: 10.10

Updated on:August 26,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on: April 28,2024

FDA approves Abecma for relapsed, refractory multiple myeloma

by Lori SolomonThe U.S. Food and Drug Administration has approved Abecma (idecabtagene vicleucel) as a personalized CAR T-cell therapy for triple-class exposed relapsed or refractory multiple myeloma.

Updated on:April 28,2024

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on: May 31,2024

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on:May 31,2024

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on: December 22,2023

A silent killer, liver cancer prompts race to improve organ replacements

by Anthony King,Horizon: The EU Research & Innovation MagazineBioprinter from Organtrans. Credit: © Gilles WederWith the only cure for liver cancer often being a transplantation, scientists

Updated on:December 22,2023

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on: December 22,2023

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on:December 22,2023

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Updated on: December 20,2023

Quantitative pathologic analysis may help predict prognosis in colorectal cancer

The quantitative segmentation algorithm (QuantCRC) may improve the prediction of prognosis in colorectal cancer (CRC), according to a study published online Aug. 16 inGastroenterology.Reetesh K.

Updated on:December 20,2023

Quitting smoking tied to better survival in head, neck squamous cell carcinoma

by Lori SolomonSmoking cessation for >10 years is significantly associated with reduced overall mortality and head and neck squamous cell carcinoma (HNSCC)-specific mortality, according to a study

Updated on: December 26,2023

Quitting smoking tied to better survival in head, neck squamous cell carcinoma

by Lori SolomonSmoking cessation for >10 years is significantly associated with reduced overall mortality and head and neck squamous cell carcinoma (HNSCC)-specific mortality, according to a study

Updated on:December 26,2023